Companies: 10,795·Total market cap: $144.5T
Adhera Therapeutics, Inc.

Adhera Therapeutics, Inc.

ATRXOTCHealthcare● Active
$0.00
$-0.00(-0.00%)
Market Cap$722
P/E Ratio—
52W High$0.01
52W Low$0.000099999997
Overview

Adhera Therapeutics, Inc. (ATRX) · Cash Flow

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · ATRX · as of 2026-06-10

Financial statements

Operating CF · CapEx · Free Cash Flow
Breakdown2022-122021-122020-122019-122018-12
Operating Activities
Net Income($0.00B)($0.01B)($0.00B)($0.01B)($0.02B)
Depreciation & Amort.$0.00B$0.00B$0.00B$0.00B$0.00B
Stock-Based Comp.$0.00B$0.00B$0.00B$0.00B$0.00B
Change in Working Capital$0.00B$0.00B$0.00B$0.00B($0.00B)
Net Cash from Operations($0.00B)($0.00B)($0.00B)($0.01B)($0.01B)
Investing Activities
Capital Expenditure$0.00B$0.00B$0.00B$0.00B($0.00B)
Purchases of Investments$0.00B$0.00B$0.00B$0.00B$0.00B
Sales of Investments$0.00B$0.00B$0.00B$0.00B$0.00B
Net Cash from Investing$0.00B$0.00B$0.00B$0.00B($0.00B)
Financing Activities
Common Stock Repurchased($0.00B)($0.00B)($0.00B)($0.00B)($0.00B)
Dividends Paid$0.00B($0.00B)($0.00B)($0.00B)($0.00B)
Debt Issued / Repaid$0.00B$0.00B$0.00B$0.00B$0.00B
Net Cash from Financing$0.00B$0.00B$0.00B$0.00B$0.01B
Free Cash Flow
Free Cash Flow($0.00B)($0.00B)($0.00B)($0.01B)($0.01B)
FCF Margin %(computed)—————

Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B

SEC 10-K filings →SEC 10-Q filings →

Explore more Adhera Therapeutics, Inc. data

Revenue History
Quarterly & annual revenue trends
Earnings Reports
EPS beats, misses & upcoming dates
P/E Ratio
Historical price-to-earnings
Dividends
Dividend history & yield
Market Cap
Historical market cap & rank
Analyst Forecast
Consensus, price targets & estimates

About Adhera Therapeutics, Inc. (ATRX) Cash Flow Statement

Adhera Therapeutics, Inc. generated operating cash flow of ($0.00B) and free cash flow of ($0.00B) for 2022 — a FCF margin of —. Capital expenditure was $0.00B.

Frequently asked questions

ATRX · 4 questions

Adhera Therapeutics, Inc. generated free cash flow of ($0.00B) for 2022, down 112.8% year-over-year.

ATRX free cash flowFCF margincash flow yield

· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10